Glenmark Life Sciences readies $203m Indian IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Glenmark Life Sciences readies $203m Indian IPO

Jonathan Breen
July 26, 2021 08:15 AM
biopharma_stocks_adobe_575x375.jpg

Pharmaceutical ingredients manufacturer Glenmark Life Sciences is set to launch a Rp15.1bn ($202.6m) IPO on Tuesday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityBank of AmericaIndiaAsiaSouth AsiaAsia PacificEmerging MarketsSRIState Bank of India SBIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article